Skip to main content
Log in

Estimating Renal Function to Reduce the Risk of Adverse Drug Reactions

  • Review Article
  • Published:
Drug Safety Aims and scope Submit manuscript

Abstract

The aging process is characterized by relevant changes in pharmacokinetics. Renal function is known to decline with aging. However, as a result of reduced muscle mass, older individuals frequently have a depressed glomerular filtration rate (GFR) despite normal serum creatinine, and such a concealed renal insufficiency may impact significantly on the clearance of hydrosoluble drugs, as well as the risk of adverse drug reactions (ADRs) from hydrosoluble drugs. The assessment of renal function should thus be a mandatory item in the global examination of patient characteristics. Equations for estimatingGFR have become very popular in recent years. However, different equations may yield significantly different estimated glomerular filtration rate (eGFR) values, which have important implications in dosing drugs cleared by the kidney. Current knowledge suggests that eGFR based on the Chronic Kidney Disease-Epidemiological Collaboration (CKD-EPI) study equation outperformed eGFR based on the Modification of Diet in Renal Disease (MDRD) study equation and creatinine clearance estimate based on the Cockcroft-Gault formula as a predictor of ADRs from kidney cleared drugs. More recently, the combined creatinine-cystatin C equation was shown to perform better than equations based on either of these markers alone in diagnosing CKD, even in older patients. However, its accuracy in predicting ADRs and usefulness in drug dosing is still to be investigated.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Inouye SK, Studenski S, Tinetti ME, et al. Geriatric syndromes: clinical, research, and policy implications of a core geriatric concept. J Am Geriatr Soc 2007 May; 55 (5): 780–91

    Article  PubMed  Google Scholar 

  2. Lee PG, Cigolle C, Blaum C. The co-occurrence of chronic diseases and geriatric syndromes: the health and retirement study. J Am Geriatr Soc 2009 Mar; 57 (3): 511–6

    Article  PubMed  Google Scholar 

  3. Cesari M, Onder G, Russo A, et al. Comorbidity and physical function: results from the aging and longevity study in the Sirente geographic area (ilSIRENTE study). Gerontology 2006; 52 (1): 24–32

    Article  PubMed  Google Scholar 

  4. Wolff JL, Starfield B, Anderson G. Prevalence, expenditures, and complications of multiple chronic conditions in the elderly. Arch Intern Med 2002 Nov 11; 162 (20): 2269–76

    Article  PubMed  Google Scholar 

  5. Onder G, Lattanzio F, Battaglia M, et al. The risk of adverse drug reactions in older patients: beyond drug metabolism. Curr Drug Metab 2011 Sep; 12 (7): 647–51

    Article  PubMed  CAS  Google Scholar 

  6. Fusco D, Lattanzio F, Tosato M, et al. Development of CRIteria to assess appropriate Medication use among Elderly complex patients (CRIME) project: rationale and methodology. Drugs Aging 2009 Dec; 26 Suppl. 1: 3–13

    Article  PubMed  Google Scholar 

  7. Olivier P, Bertrand L, Tubery M, et al. Hospitalizations because of adverse drug reactions in elderly patients admitted through the emergency department: a prospective survey. Drugs Aging 2009; 26 (6): 475–82

    Article  PubMed  Google Scholar 

  8. Zhang M, Holman CD, Price SD, et al. Comorbidity and repeat admission to hospital for adverse drug reactions in older adults: retrospective cohort study. BMJ 2009; 338: a2752

    Article  PubMed  Google Scholar 

  9. Onder G, Pedone C, Landi F, et al. Adverse drug reactions as cause of hospital admissions: results from the Italian Group of Pharmacoepidemiology in the Elderly (GIFA). J Am Geriatr Soc 2002 Dec; 50 (12): 1962–8

    Article  PubMed  Google Scholar 

  10. Tulner LR, Frankfort SV, Gijsen GJ, et al. Drug-drug interactions in a geriatric outpatient cohort: prevalence and relevance. Drugs Aging 2008; 25 (4): 343–55

    Article  PubMed  Google Scholar 

  11. Becker ML, Visser LE, van Gelder T, et al. Increasing exposure to drug-drug interactions between 1992 and 2005 in people aged > or = 55 years. Drugs Aging 2008; 25 (2): 145–52

    Article  PubMed  Google Scholar 

  12. Corsonello A, Pedone C, Incalzi RA. Age-related pharmacokinetic and pharmacodynamic changes and related risk of adverse drug reactions. CurrMed Chem 2010; 17 (6): 571–84

    CAS  Google Scholar 

  13. Shi S, Klotz U. Age-related changes in pharmacokinetics. Curr Drug Metab 2011 Sep; 12 (7): 601–10

    Article  PubMed  CAS  Google Scholar 

  14. Trifiro G, Spina E. Age-related changes in pharmacodynamics: focus on drugs acting on central nervous and cardiovascular systems. Curr Drug Metab 2011 Sep; 12 (7): 611–20

    Article  PubMed  CAS  Google Scholar 

  15. Lindeman RD. Assessment of renal function in the old. Special considerations. Clin Lab Med 1993 Mar; 13 (1): 269–77

    PubMed  CAS  Google Scholar 

  16. Fliser D, Franek E, Ritz E. Renal function in the elderly — is the dogma of an inexorable decline of renal function correct? Nephrol Dial Transplant 1997 Aug; 12 (8): 1553–5

    Article  PubMed  CAS  Google Scholar 

  17. Sokoll LJ, Russell RM, Sadowski JA, et al. Establishment of creatinine clearance reference values for older women. Clin Chem 1994 Dec; 40 (12): 2276–81

    PubMed  CAS  Google Scholar 

  18. Fliser D, Franek E, Joest M, et al. Renal function in the elderly: impact of hypertension and cardiac function. Kidney Int 1997 Apr; 51 (4): 1196–204

    Article  PubMed  CAS  Google Scholar 

  19. Beck LH. Changes in renal function with aging. Clin Geriatr Med 1998 May; 14 (2): 199–209

    PubMed  CAS  Google Scholar 

  20. Miletic D, Fuckar Z, Sustic A, et al. Sonographic measurement of absolute and relative renal length in adults. J Clin Ultrasound 1998 May; 26 (4): 185–9

    Article  PubMed  CAS  Google Scholar 

  21. Fuiano G, Sund S, Mazza G, et al. Renal hemodynamic response to maximal vasodilating stimulus in healthy older subjects. Kidney Int 2001 Mar; 59 (3): 1052–8

    Article  PubMed  CAS  Google Scholar 

  22. Melk A, Halloran PF. Cell senescence and its implications for nephrology. J Am Soc Nephrol 2001 Feb; 12 (2): 385–93

    PubMed  CAS  Google Scholar 

  23. Neugarten J, Gallo G, Silbiger S, et al. Glomerulosclerosis in aging humans is not influenced by gender. Am J Kidney Dis 1999 Nov; 34 (5): 884–8

    Article  PubMed  CAS  Google Scholar 

  24. Turnheim K. When drug therapy gets old: pharmacokinetics and pharmacodynamics in the elderly. Exp Gerontol 2003 Aug; 38 (8): 843–53

    Article  PubMed  CAS  Google Scholar 

  25. Davies DF, Shock NW. Age changes in glomerular filtration rate, effective renal plasma flow, and tubular excretory capacity in adultmales. J Clin Invest 1950 May; 29 (5): 496–507

    Article  PubMed  CAS  Google Scholar 

  26. Hollenberg NK, Rivera A, Meinking T, et al. Age, renal perfusion and function in island-dwelling indigenous Kuna Amerinds of Panama. Nephron 1999 Jun; 82 (2): 131–8

    Article  PubMed  CAS  Google Scholar 

  27. Fliser D, Ritz E. Serum cystatin C concentration as a marker of renal dysfunction in the elderly. Am J Kidney Dis 2001 Jan; 37 (1): 79–83

    PubMed  CAS  Google Scholar 

  28. Lindeman RD, Tobin J, Shock NW. Longitudinal studies on the rate of decline in renal function with age. J Am Geriatr Soc 1985 Apr; 33 (4): 278–85

    PubMed  CAS  Google Scholar 

  29. Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA 2007 Nov 7; 298 (17): 2038–47

    Article  PubMed  CAS  Google Scholar 

  30. Heuberger RA, Caudell K. Polypharmacy and nutritional status in older adults: a cross-sectional study. Drugs Aging 2011 Apr 1; 28 (4): 315–23

    Article  PubMed  Google Scholar 

  31. Linjakumpu T, Hartikainen S, Klaukka T, et al. Use of medications and polypharmacy are increasing among the elderly. J Clin Epidemiol 2002 Aug; 55 (8): 809–17

    Article  PubMed  Google Scholar 

  32. Kappel J, Calissi P. Nephrology: 3. Safe drug prescribing for patients with renal insufficiency. CMAJ 2002 Feb 19; 166 (4): 473–7

    PubMed  Google Scholar 

  33. Gabardi S, Abramson S. Drug dosing in chronic kidney disease. Med Clin North Am 2005 May; 89 (3): 649–87

    Article  PubMed  CAS  Google Scholar 

  34. Hassan Y, Al-Ramahi R, Abd Aziz N, et al. Drug use and dosing in chronic kidney disease. Ann Acad Med Singapore 2009 Dec; 38 (12): 1095–103

    PubMed  Google Scholar 

  35. Pillans PI, Landsberg PG, Fleming AM, et al. Evaluation of dosage adjustment in patients with renal impairment. Intern Med J 2003 Jan–Feb; 33 (1–2): 10–3

    Article  Google Scholar 

  36. Yap C, Dunham D, Thompson J, et al. Medication dosing errors for patients with renal insufficiency in ambulatory care. Jt Comm J Qual Patient Saf 2005 Sep; 31 (9): 514–21

    PubMed  Google Scholar 

  37. Onder G, Petrovic M, Tangiisuran B, et al. Development and validation of a score to assess risk of adverse drug reactions among in-hospital patients 65 years or older: the GerontoNet ADR risk score. Arch Intern Med 2010 Jul 12; 170 (13): 1142–8

    Article  PubMed  Google Scholar 

  38. Corsonello A, Pedone C, Lattanzio F, et al. Association between glomerular filtration rate and adverse drug reactions in elderly hospitalized patients: the role of the estimating equation. Drugs Aging 2011 May 1; 28 (5): 379–90

    Article  PubMed  Google Scholar 

  39. Gurwitz JH, Field TS, Harrold LR, et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA 2003 Mar 5; 289 (9): 1107–16

    Article  PubMed  Google Scholar 

  40. Pirmohamed M, James S, Meakin S, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ 2004 Jul 3; 329 (7456): 15–9

    Article  PubMed  Google Scholar 

  41. Inker LA, Schmid CH, Tighiouart H, et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med 2012 Jul 5; 367 (1): 20–9

    Article  PubMed  CAS  Google Scholar 

  42. Kilbride HS, Stevens PE, Eaglestone G, et al. Accuracy of the MDRD (Modification of Diet in Renal Disease) Study and CKD-EPI (CKD Epidemiology Collaboration) equations for estimation of GFR in the elderly. Am J Kidney Dis 2012 Aug 11. [Epub ahead of print]

    Google Scholar 

  43. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16 (1): 31–41

    Article  PubMed  CAS  Google Scholar 

  44. Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999 Mar 16; 130 (6): 461–70

    PubMed  CAS  Google Scholar 

  45. Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009 May 5; 150 (9): 604–12

    PubMed  Google Scholar 

  46. Corsonello A, Pedone C, Lattanzio F, et al. Does concealed chronic kidney disease predict survival of older patients discharged from acute care hospitals? Rejuvenation Res 2010 Oct; 13 (5): 539–45

    Article  PubMed  Google Scholar 

  47. Swedko PJ, Clark HD, Paramsothy K, et al. Serum creatinine is an inadequate screening test for renal failure in elderly patients. Arch Intern Med 2003 Feb 10; 163 (3): 356–60

    Article  PubMed  CAS  Google Scholar 

  48. Fielding RA, Vellas B, Evans WJ, et al. Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International Working Group on Sarcopenia. J Am Med Dir Assoc 2011 May; 12 (4): 249–56

    Article  PubMed  Google Scholar 

  49. Rolland Y, Czerwinski S, Abellan van Kan G, et al. Sarcopenia: its assessment, etiology, pathogenesis, consequences and future perspectives. J Nutr Health Aging 2008 Aug–Sep; 12 (7): 433–50

    Article  PubMed  CAS  Google Scholar 

  50. Jonville-Bera AP, Paroux L, Autret-Leca E. Assessing general practitioners’ prescribing behaviour in elderly patients with concealed renal failure. Br J Clin Pharmacol 2008 Jun; 65 (6): 961–3

    Article  PubMed  Google Scholar 

  51. Corsonello A, Pedone C, Corica F, et al. Concealed renal insufficiency and adverse drug reactions in elderly hospitalized patients. Arch Intern Med 2005 Apr 11; 165 (7): 790–5

    Article  PubMed  Google Scholar 

  52. Corsonello A, Pedone C, Corica F, et al. Concealed renal failure and adverse drug reactions in older patients with type 2 diabetes mellitus. J Gerontol A Biol Sci Med Sci 2005 Sep; 60 (9): 1147–51

    Article  PubMed  Google Scholar 

  53. Pedone C, Corsonello A, Incalzi RA. Estimating renal function in older people: a comparison of three formulas. Age Ageing 2006 Mar; 35 (2): 121–6

    Article  PubMed  Google Scholar 

  54. Hudson JQ, Nyman HA. Use of estimated glomerular filtration rate for drug dosing in the chronic kidney disease patient. Curr Opin Nephrol Hypertens 2011 Sep; 20 (5): 482–91

    Article  PubMed  CAS  Google Scholar 

  55. Stevens LA, Nolin TD, Richardson MM, et al. Comparison of drug dosing recommendations based on measured GFR and kidney function estimating equations. Am J Kidney Dis 2009 Jul; 54 (1): 33–42

    Article  PubMed  CAS  Google Scholar 

  56. Corsonello A, Pedone C, Lattanzio F, et al. Agreement between equations estimating glomerular filtration rate in elderly nursing home residents and in hospitalised patients: implications for drug dosing. Age Ageing 2011 Sep; 40 (5): 583–9

    Article  PubMed  Google Scholar 

  57. Stevens LA, Coresh J, Greene T, et al. Assessing kidney function-measured and estimated glomerular filtration rate. N Engl J Med 2006 Jun 8; 354 (23): 2473–83

    Article  PubMed  CAS  Google Scholar 

  58. Pedone C, Semeraro R, Chiurco D, et al. Reliability of equations to estimate glomerular filtration rate in the very old. Aging Clin Exp Res 2008 Dec; 20 (6): 496–502

    PubMed  Google Scholar 

  59. Corsonello A, Lattanzio F, Incalzi RA. Estimating glomerular filtration rate. N Engl J Med 2012 Sep 27; 367 (13): 1261; author reply 3–4

    Article  PubMed  Google Scholar 

  60. Macdonald J, Marcora S, Jibani M, et al. GFR estimation using cystatin C is not independent of body composition. Am J Kidney Dis 2006 Nov; 48 (5): 712–9

    Article  PubMed  CAS  Google Scholar 

  61. Long CL, Raebel MA, Price DW, et al. Compliance with dosing guidelines in patients with chronic kidney disease. Ann Pharmacother 2004 May; 38 (5): 853–8

    Article  PubMed  Google Scholar 

  62. Geara AS, Azzi N, Ghimire P, et al. The impact of reporting estimated glomerular filtration rate. Ren Fail 2011; 33 (5): 486–8

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Andrea Corsonello.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Corsonello, A., Onder, G., Bustacchini, S. et al. Estimating Renal Function to Reduce the Risk of Adverse Drug Reactions. Drug Saf 35 (Suppl 1), 47–54 (2012). https://doi.org/10.1007/BF03319102

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03319102

Keywords

Navigation